Volume 9, Issue 5, Pages (May 2002)

Slides:



Advertisements
Similar presentations
Volume 9, Issue 5, Pages (May 2002)
Advertisements

The Structural Basis for :Phosphopeptide Binding Specificity
Volume 115, Issue 1, Pages (October 2003)
Crystal Structure of the Tandem Phosphatase Domains of RPTP LAR
The FHA Domain Is a Modular Phosphopeptide Recognition Motif
Phosphorylation of NF-κB p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300  Haihong.
Volume 15, Issue 5, Pages (September 2004)
The C2 Domain of PKCδ Is a Phosphotyrosine Binding Domain
Volume 87, Issue 7, Pages (December 1996)
Volume 12, Issue 2, Pages (August 2003)
Volume 18, Issue 1, Pages (April 2005)
Volume 7, Issue 1, Pages (April 2014)
Volume 21, Issue 9, Pages (September 2013)
Volume 115, Issue 2, Pages (October 2003)
Volume 64, Issue 3, Pages (November 2016)
Tom Huxford, De-Bin Huang, Shiva Malek, Gourisankar Ghosh  Cell 
Volume 108, Issue 6, Pages (March 2002)
Yvonne Groemping, Karine Lapouge, Stephen J. Smerdon, Katrin Rittinger 
The TGFβ Receptor Activation Process
Volume 36, Issue 4, Pages (November 2009)
Structure of the TPR Domain of p67phox in Complex with Rac·GTP
Volume 111, Issue 3, Pages (November 2002)
Phospho-Pon Binding-Mediated Fine-Tuning of Plk1 Activity
Crystal Structures of Oligomeric Forms of the IP-10/CXCL10 Chemokine
Diabetes Mutations Delineate an Atypical POU Domain in HNF-1α
Solution and Crystal Structures of a Sugar Binding Site Mutant of Cyanovirin-N: No Evidence of Domain Swapping  Elena Matei, William Furey, Angela M.
Volume 11, Issue 5, Pages (May 2003)
Yanhui Xu, Yu Chen, Ping Zhang, Philip D. Jeffrey, Yigong Shi 
Volume 20, Issue 1, Pages 9-19 (October 2005)
Role of the regulatory domain of the EGF-receptor cytoplasmic tail in selective binding of the clathrin-associated complex AP-2  Werner Boll, Andreas.
WNK1 Phosphorylates Synaptotagmin 2 and Modulates Its Membrane Binding
Structural Basis for Protein Recognition by B30.2/SPRY Domains
Zhenjian Cai, Nabil H. Chehab, Nikola P. Pavletich  Molecular Cell 
Volume 7, Issue 2, Pages (February 2001)
Structure of the Catalytic Domain of Human DOT1L, a Non-SET Domain Nucleosomal Histone Methyltransferase  Jinrong Min, Qin Feng, Zhizhong Li, Yi Zhang,
Volume 95, Issue 7, Pages (December 1998)
Structural Basis of EZH2 Recognition by EED
Structure and Regulation of the CDK5-p25nck5a Complex
Claudia Schneider, James T. Anderson, David Tollervey  Molecular Cell 
Volume 16, Issue 12, Pages (December 2008)
Volume 18, Issue 12, Pages (December 2010)
Frida E. Kleiman, James L. Manley  Cell 
Volume 90, Issue 4, Pages (August 1997)
Structural Basis of Caspase-7 Inhibition by XIAP
Structural Analysis of the Protein Phosphatase 1 Docking Motif: Molecular Description of Binding Specificities Identifies Interacting Proteins  Heike.
Volume 6, Issue 4, Pages (October 2000)
Mechanisms Contributing to T Cell Receptor Signaling and Assembly Revealed by the Solution Structure of an Ectodomain Fragment of the CD3ϵγ Heterodimer 
Volume 52, Issue 3, Pages (November 2013)
Structure of the BRCT Repeats of BRCA1 Bound to a BACH1 Phosphopeptide
Michael S. Kuhns, Mark M. Davis  Immunity 
Volume 123, Issue 7, Pages (December 2005)
Volume 9, Issue 5, Pages (May 2002)
Silva H Hanissian, Raif S Geha  Immunity 
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Jue Wang, Jia-Wei Wu, Zhi-Xin Wang  Structure 
Volume 132, Issue 2, Pages (January 2008)
Jia-Wei Wu, Amy E. Cocina, Jijie Chai, Bruce A. Hay, Yigong Shi 
Structure of an IκBα/NF-κB Complex
DAPK interacts with HSF1 in vivo and in vitro.
Volume 7, Issue 6, Pages (June 2001)
The Structure of the GGA1-GAT Domain Reveals the Molecular Basis for ARF Binding and Membrane Association of GGAs  Brett M. Collins, Peter J. Watson,
by Kevin J. Paavola, Harwin Sidik, J
Volume 2, Issue 3, Pages (September 1998)
Volume 12, Issue 6, Pages (March 2002)
Volume 21, Issue 6, Pages (June 2013)
A Common Phosphate Binding Site Explains the Unique Substrate Specificity of GSK3 and Its Inactivation by Phosphorylation  Sheelagh Frame, Philip Cohen,
Volume 4, Issue 4, Pages (October 1999)
Crystal Structure of a Phosphorylated Smad2
Volume 15, Issue 5, Pages (May 2007)
Volume 15, Issue 6, Pages (September 2004)
Presentation transcript:

Volume 9, Issue 5, Pages 1045-1054 (May 2002) Structural and Functional Versatility of the FHA Domain in DNA-Damage Signaling by the Tumor Suppressor Kinase Chk2  Jiejin Li, Brandi L. Williams, Lesley F. Haire, Michal Goldberg, Erik Wilker, Daniel Durocher, Michael B. Yaffe, Stephen P. Jackson, Stephen J. Smerdon  Molecular Cell  Volume 9, Issue 5, Pages 1045-1054 (May 2002) DOI: 10.1016/S1097-2765(02)00527-0

Figure 1 Chk2 FHA Structure and Peptide Binding (A) Oriented peptide library screen for Chk2 FHA phosphothreonine binding specificity. Selectivity ratios (Durocher et al., 2000) for the primary and refinement screens are in parentheses. For the refinement screen, a second phosphopeptide library was synthesized with an isoleucine residue fixed at the pT +3 position. Amino acids are in single-letter code. (B) Binding of Chk2 FHA to the optimal phosphopeptide measured by isothermal titration calorimetry, essentially as described previously (Durocher et al., 2000). (C) Structure of the Chk2 FHA domain in complex with the selected phosphopeptide. Molecular Cell 2002 9, 1045-1054DOI: (10.1016/S1097-2765(02)00527-0)

Figure 2 Structural Basis of Binding Specificity (A) Schematic representation of protein-peptide contacts. Hydrogen bonds are shown as dotted lines with nonpolar/van der Waals interactions indicated by arcs and interacting peptide side chains highlighted in red. Highly conserved residues are highlighted in green. (B) Least-squares superposition of the Chk2 FHA (white) with Rad53p FHA1 (blue) as a backbone worm shown in stereo. The phosphopeptide from the Chk2 complex is also shown in worm representation with the pThr and Ile +3 side chains highlighted in ball-and-stick. The β4-β5 and β10-β11 loop regions are highlighted in red (Chk2) and green (Rad53p), respectively. Molecular Cell 2002 9, 1045-1054DOI: (10.1016/S1097-2765(02)00527-0)

Figure 3 Chk2 Regulation Is Variably Affected by Mutations in the FHA Domain (A) Surface plasmon resonance was used to measure the relative binding of approximately equal concentrations of wild-type (WT) and mutated GST-Chk2 FHA fusion proteins to biotinylated peptides immobilized on streptavidin-coated sensor chips. The peptides contain the sequence RHFD(T)YLIRR in which the threonine was either unphosphorylated (T) or phosphorylated (pT). (B) Extracts were prepared from 293T cells transfected with the indicated plasmid DNA and treated with phleomycin (+) or PBS (−). HA-tagged Chk2 was immunoprecipitated with anti-HA antibody and immunoblotted with anti-Chk2 (pThr68) antibody (upper panel). The blot was stripped and reprobed with anti-HA antibody (lower panel). (C) 293T cells were transfected with pRc/CMV (Vec) or with pRc/CMV-HAChk2 having wild-type sequence (WT), an inactivating mutation in the kinase domain (KD), or the indicated missense mutation. After exposure to phleomycin (+) or PBS (−), 50 μg of total protein extract was probed with anti-HA antibody. The unphosphorylated (Chk2) and phosphorylated (Chk2-P) forms are indicated by arrows. Nonspecific species are present to a greater or lesser extent in all samples and are indicated by an asterisk. (D) Both Arg145 and Ile157 are located on the more conserved face of the FHA domain β sandwich, and they are remote from the site of phosphopeptide binding. Arg117 forms a conserved contact with the phosphothreonine. (E) Arg145 forms an extensive series of van der Waals and hydrogen bonding interactions with a constellation of residues located on β strands 3, 5, and 6. Molecular Cell 2002 9, 1045-1054DOI: (10.1016/S1097-2765(02)00527-0)

Figure 4 The Chk2 FHA Domain Specifically Binds BRCA1 in Phospho-Dependent and -Independent Manners (A) Wild-type (WT) or mutated GST-Chk2FHA fusion proteins were incubated with extracts from undamaged (C), HU treated (H), or phleomycin treated (P) HeLa cells. Bound proteins were analyzed by Western blot using anti-BRCA1 antibody (BRCA1 Ab-1, Oncogene Research Products). (B) Extracts from HU-treated HeLa cells (prepared in the absence of phosphatase inhibitors) were treated with 1000 units of λ phosphatase in the absence or presence of 50 mM EDTA for 30 min at 30°C. Extracts were incubated with the GST-Chk2 FHA fusion protein, and bound proteins (lower panel) or 50 μg of total protein (upper panel) was immunoblotted with anti-BRCA1 antibody. (C) GST-Chk2FHA fusion protein was incubated with HeLa cell extracts in the absence or presence of increasing amounts of peptide with the sequence RHFDpTYLIRR (pT-Y-L-I). Bound BRCA1 was analyzed by Western blot. (D) Wild-type (WT) or mutant GST-CHK2 FHA fusion proteins were incubated with extracts from γ-irradiated MCF-7 cells, and bound proteins were analyzed by 2-D electrophoresis. One representative section of the resulting gel is shown. Proteins that bound to the wild-type FHA domain but not to either the R117A or I157T mutant FHA domains are highlighted by ovals. Proteins displaying nearly equivalent interactions with wild-type and mutant domains are enclosed in diamond-shaped symbols, and those showing semiconserved interactions are enclosed in squares. Molecular Cell 2002 9, 1045-1054DOI: (10.1016/S1097-2765(02)00527-0)

Figure 5 Comparison of Chk2 FHA and Smad2 MH2 Complexes (A) The structurally related β sandwich domains are shown in the same orientation, each superimposed with the phosphopeptide (pP) derived from the Chk2 FHA complex structure and the SARA adaptor protein derived from the MH2 domain complex (Wu et al., 2000). The side chains of Ile157 from Chk2 and Arg330 and His331 from Smad2 are shown in space-filling representation. Mutation of Arg330 and His331 severely reduces interaction of Smad2 with phosphorylated TGFβ receptor (Huse et al., 2001). (B) Structure of a phosphorylated Smad2 MH2 trimer viewed along the 3-fold axis (Wu et al., 2001a). The C-terminal region is highlighted in red. The Chk2 FHA domain (green) is shown superimposed on one MH2 monomer, and the relative position of the phosphopeptide (pP) to that of the Smad C-terminal interacting region is shown. Molecular Cell 2002 9, 1045-1054DOI: (10.1016/S1097-2765(02)00527-0)